Discovering

A disciplined, highly targeted approach to discovering new cancer medicines

Go

Developing

Rigorous, definitive clinical trials based on deep oncology expertise

Go

Delivering

Committed to bringing differentiated new cancer medicines to patients

Go

Iclusig®(ponatinib)

ARIAD's first internally discovered and developed medicine

Go
       

News & Features

Latest News

3/25/15

ARIAD Announces Dismissal of Shareholder Class Action Lawsuit in Federal District Court

Read More

3/24/15

ARIAD and Medison Pharma Announce Approval of Iclusig (Ponatinib) in Israel

Read More

Our Corporate Brochure

A shared commitment to patients and each other. This is ARIAD.

click here for PDF

Print page Share page
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue